SynthesisWorld journal of urology2018

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer.

Francesco Soria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.